For mTORC1 and mTORC2 signaling, the elevated basal levels in AD lymphocytes prior to simufilam treatment were comparable to insulin-stimulated levels in healthy controls, leaving little room for further stimulation by insulin. The gene discussed is INS; the disease is Alzheimer disease.